Cyclo Therapeutics, Inc.
CYTH · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,833 | -$5,981 | -$4,343 | -$5,642 |
| Dep. & Amort. | $2 | $2 | $2 | $5 |
| Deferred Tax | $0 | $0 | $0 | -$62 |
| Stock-Based Comp. | -$18 | $366 | $173 | $258 |
| Change in WC | $972 | $1,146 | -$2,118 | $1,032 |
| Other Non-Cash | -$316 | $619 | $1,787 | $115 |
| Operating Cash Flow | -$8,192 | -$3,848 | -$6,182 | -$4,295 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,848 | $3,848 | $0 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$2 |
| Investing Cash Flow | $0 | $0 | $0 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $8,000 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $510 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $1,975 | -$69 | $11,232 |
| Financing Cash Flow | $7,999 | $1,975 | -$69 | $11,742 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$194 | -$1,873 | -$6,251 | $7,445 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,122 | $2,995 | $9,247 | $1,802 |
| End Cash | $928 | $1,122 | $2,995 | $9,247 |
| Free Cash Flow | -$12,041 | -$3,848 | -$6,182 | -$4,297 |